Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chloroquine for Symptomatic Persistent Atrial Fibrillation
NCT02932007Phase 2Recruiting
- Sponsor
- University of South Florida
- Start
- Mar 2017
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of chloroquine in Atrial fibrillation (AFib), sponsored by University of South Florida. Started Mar 2017; status: recruiting.
02
Drugs
chloroquine
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT02932007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02932007.